Inventor
RAMURTHY SAVITHRI
US37 patents
⚠️ This page may combine multiple inventors who share the name “RAMURTHY SAVITHRI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS VACCINES & DIAGNOSTIC
11 patentsUS7482367B2Jan 27, 2009
Substituted benzimidazoles and methods of their use
NOVARTIS VACCINES & DIAGNOSTIC40 citations94
US7691866B2Apr 6, 2010
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of Raf kinase
NOVARTIS VACCINES & DIAGNOSTIC22 citations92
US7425557B2Sep 16, 2008
Inhibitors of glycogen synthase kinase 3
NOVARTIS VACCINES & DIAGNOSTIC19 citations92
US7553854B2Jun 30, 2009
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
NOVARTIS VACCINES & DIAGNOSTIC20 citations90
US7470709B2Dec 30, 2008
Benzimidazole quinolinones and uses thereof
NOVARTIS VACCINES & DIAGNOSTIC36 citations90
US7732465B2Jun 8, 2010
Substituted benzimidazoles and methods of their use
NOVARTIS VACCINES & DIAGNOSTIC5 citations72
US7728010B2Jun 1, 2010
Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
NOVARTIS VACCINES & DIAGNOSTIC5 citations72
US7576221B2Aug 18, 2009
Substituted imidazole derivatives
NOVARTIS VACCINES & DIAGNOSTIC5 citations71
US7671049B2Mar 2, 2010
Pyrrole based inhibitors of glycogen synthase kinase 3
NOVARTIS VACCINES & DIAGNOSTIC4 citations63
US7384942B2Jun 10, 2008
Pyrazine based inhibitors of glycogen synthase kinase 3
NOVARTIS VACCINES & DIAGNOSTIC1 citations52
US7626040B2Dec 1, 2009
Substituted imidazole compounds as KSP inhibitors
NOVARTIS VACCINES & DIAGNOSTIC1 citations47
NOVARTIS AG
9 patentsUS9242969B2Jan 26, 2016
Biaryl amide compounds as kinase inhibitors
NOVARTIS AG35 citations92
US7423150B2Sep 9, 2008
Substituted benzazoles and methods of their use as inhibitors of Raf kinase
NOVARTIS AG16 citations91
US7932262B2Apr 26, 2011
Quinazolines for PDK1 inhibition
NOVARTIS AG24 citations89
US9694016B2Jul 4, 2017
Biaryl amide compounds as kinase inhibitors
NOVARTIS AG5 citations82
US10709712B2Jul 14, 2020
Biaryl amide compounds as kinase inhibitors
NOVARTIS AG3 citations70
US10245267B2Apr 2, 2019
Biaryl amide compounds as kinase inhibitors
NOVARTIS AG3 citations70
US10167279B2Jan 1, 2019
Compounds and compositions as RAF kinase inhibitors
NOVARTIS AG3 citations69
US10377770B2Aug 13, 2019
Tricyclic compounds and compositions as kinase inhibitors
NOVARTIS AG1 citations59
US10392404B2Aug 27, 2019
Compounds and compositions as kinase inhibitors
NOVARTIS AG0 citations38
CHIRON CORP
7 patentsUS7037918B2May 2, 2006
Inhibitors of glycogen synthase kinase 3
CHIRON CORP49 citations96
US6608063B2Aug 19, 2003
Pyrazine based inhibitors of glycogen synthase kinase 3
CHIRON CORP64 citations96
US6489344B1Dec 3, 2002
Inhibitors of glycogen synthase kinase 3
CHIRON CORP76 citations96
US7045519B2May 16, 2006
Inhibitors of glycogen synthase kinase 3
CHIRON CORP46 citations92
US6949547B2Sep 27, 2005
Pyrazine based inhibitors of glycogen synthase kinase 3
CHIRON CORP17 citations92
US7071216B2Jul 4, 2006
Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
CHIRON CORP37 citations91
US7250443B2Jul 31, 2007
Pyrrole based inhibitors of glycogen synthase kinase 3
CHIRON CORP8 citations74